Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3703, Durham, NC 27710
Phone (919) 681-6386
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine/Nephrology, Vice Chair for Faculty Development and Diversity in the Department of Medicine, and School of Medicine Faculty Ombudsperson. She is also the Director of Duke’s CTSA-sponsored internal career development award program (KL2) and the Investigator Development Core of Duke’s REACH Equity Disparities Research Center.

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is an American Society of Hypertension certified hypertension specialist, and a member of the Association of American Physicians (AAP). She is the Associate Director, Core Director and Project PI of Duke’s REACH Equity Disparities Research Center.

As Department of Medicine Vice Chair for Faculty Development and Diversity, she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

As School of Medicine Faculty Ombudsperson, she helps faculty resolve concerns by providing confidential, impartial, informal guidance.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

SMITH, S. R., P. E. KLOTMAN, and L. P. SVETKEY. “ACUTE EFFECT OF ORAL POTASSIUM ON BLOOD-PRESSURE AND RENAL-FUNCTION IN MILD HYPERTENSION.” Clinical Research 38, no. 1 (January 1, 1990): A22–A22.

Scholars@Duke

Svetkey, L. P., S. I. Himmelstein, N. R. Dunnick, R. H. Wilkinson, R. R. Bollinger, R. L. McCann, E. M. Beytas, and P. E. Klotman. “Prospective analysis of strategies for diagnosing renovascular hypertension..” Hypertension 14, no. 3 (September 1989): 247–57. https://doi.org/10.1161/01.hyp.14.3.247.

PMID
2670763
Full Text

SVETKEY, L. P., and P. E. KLOTMAN. “CAPTOPRIL-STIMULATED PLASMA-RENIN AND THE CAPTOPRIL TEST AS SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION.” Clinical Research 37, no. 2 (April 1, 1989): A401–A401.

Scholars@Duke

Dunnick, N. R., L. P. Svetkey, R. H. Cohan, G. E. Newman, S. D. Braun, S. I. Himmelstein, R. R. Bollinger, R. L. McCann, R. H. Wilkinson, and P. E. Klotman. “Intravenous digital subtraction renal angiography: use in screening for renovascular hypertension..” Radiology 171, no. 1 (April 1989): 219–22. https://doi.org/10.1148/radiology.171.1.2648471.

PMID
2648471
Full Text

SVETKEY, L. P., and P. E. KLOTMAN. “CAPTOPRIL TEST VERSUS CAPTOPRIL-STIMULATED PLASMA-RENIN AS SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION.” Kidney International 35, no. 1 (January 1, 1989): 335–335.

Scholars@Duke

Svetkey, L. P., R. Brobyn, P. Deedwania, R. M. Graham, J. Morganroth, and P. E. Klotman. “Double-blind comparison of doxazosin, nadolol, and placebo in patients with mild-to-moderate hypertension.” Current Therapeutic Research  Clinical and Experimental 43, no. 5 (January 1, 1988): 969–78.

Scholars@Duke

Svetkey, L. P., N. R. Dunnick, T. M. Coffman, S. I. Himmelstein, R. R. Bollinger, R. L. McCann, R. H. Wilkinson, S. D. Braun, G. F. Newman, and R. H. Cohan. “Comparison of intravenous digital subtraction angiography and conventional arteriography in defining renal anatomy..” Transplantation 45, no. 1 (January 1988): 56–58. https://doi.org/10.1097/00007890-198801000-00013.

PMID
3276063
Full Text

Svetkey, L. P., M. H. Weinberger, H. Gavras, I. Gavras, T. S. Brown, J. Deterding, and P. E. Klotman. “Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension..” J Clin Hypertens 3, no. 4 (December 1987): 579–88.

PMID
3330988
Scholars@Duke

Svetkey, L. P., W. E. Yarger, J. R. Feussner, E. DeLong, and P. E. Klotman. “Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension..” Hypertension 9, no. 5 (May 1987): 444–50. https://doi.org/10.1161/01.hyp.9.5.444.

PMID
3570421
Full Text

Mulrow, C. D., B. L. Dolmatch, E. R. Delong, J. R. Feussner, M. C. Benyunes, J. L. Dietz, S. K. Lucas, E. D. Pisano, L. P. Svetkey, and B. D. Volpp. “Observer variability in the pulmonary examination..” J Gen Intern Med 1, no. 6 (November 1986): 364–67. https://doi.org/10.1007/bf02596418.

PMID
3794835
Full Text

Pages